San Francisco-based mortgage startup LoanSnap has raised $8 million in Series A financing. True Ventures led the round with participation from other investors that included Baseline Ventures, Virgin Group, Core Innovation Partners, Liquid 2 Ventures, OVO Fund and Transmedia Ventures.
1 min read · 20 July 2018
Ashland, Oregon-based HerdDogg, a provider of precision livestock and remote animal health, has secured $2.3 million in seed financing. Serra Ventures led the round. As part of the transaction, Rob Schultz from Serra Ventures and Tom Trone, a former John Deere executive, have joined HerdDogg’s board of directors.
1 min read · 20 July 2018
Hemper, a cannabis accessories and lifestyle brand, has raised $1 million in seed funding. The investor was Evolution Corporate Advisors.
1 min read · 20 July 2018
Singapore-based Points, a blockchain data collaboration protocol for better credit scoring and inclusive finance, has raised $8 million in funding. The investors included DHVC, Cherubic Ventures, Ce Yuan, Ontology Foundation, Nest.Bio Ventures and Zhong Cheng Xin Credit Technology.
1 min read · 20 July 2018
Ursa Space Systems, a provider of geospatial intelligence solutions, has secured $5.7 million in funding. RRE Ventures led the round with participation from other investors that included S&P Global and Paladin Capital Group.
1 min read · 20 July 2018
Laurel Venture Capital has acquired Alpine Immune Sciences' S-Nitrosoglutathione Reductase assets. No financial terms were disclosed. Seattle-based Alpine is focused on discovering and developing protein-based immunotherapies to treat cancer, autoimmune/inflammatory illnesses and other diseases.
3 min read · 20 July 2018
Lifebit, a genomics data startup, has raised $3 million in seed funding. Pentech and Connect Ventures led the round with participation from Beacon Capital and Tiny VC.
4 min read · 19 July 2018
Cambridge, Massachusetts-based Constellation Pharmaceuticals Inc, a developer of tumor-targeted and immuno-oncology therapies, has raised $60 million for its IPO after pricing its 4 million shares at $15 per share. The stock began trading July 19, 2018 on the NASDAQ under the ticker symbol "CNST." J.P. Morgan, Jefferies and BMO Capital Markets are the lead underwriters. The investors included Cormorant Asset Management, Deerfield Management, Fidelity Management and Research Company, Hillhouse Capital, NS Investment, OrbiMed, Sirona Capital, Venrock Healthcare Partners, The Column Group, Third Rock Ventures, Venrock, SROne, University of California Investment Office, Topspin Partners and Casdin Capital.
2 min read · 19 July 2018
San Carlos, California-based Allakos, a developer of antibodies that treat various eosinophil and mast cell related diseases, has raised about $128.4 million for its IPO after pricing its over 7.1 million shares at $18 per share. The stock began trading July 19, 2018 on the NASDAQ under the ticker symbol "ALLK." Goldman Sachs and Jefferies LLC are the lead underwriters. Allakos' pre-IPO backers include Novo Ventures, Alta Partners, RiverVest Venture Partners and the Roche Venture Fund.
1 min read · 19 July 2018
Menlo Park, California-based Quantapore Inc, a biotech firm, has closed $15.55 million in funding. Northern Light Venture Capital led the round with participation from Tsingyuan Ventures, Sangel Venture Capital, Baidu Ventures and Cloudstone VC. In addition to the funding, Feng Deng of NLVC has joined Quantapore’s board of directors.
1 min read · 19 July 2018
